[FATE] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 9.12%
YoY- -6.63%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 2,802 1,661 1,027 1,027 1,076 0 -971 -
PBT -28,302 -16,027 -12,497 -7,940 -7,446 -6,233 -5,739 30.45%
Tax 691 817 -131 -160 -207 -124 -1,633 -
NP -28,302 -16,027 -12,497 -7,940 -7,446 -6,233 -5,739 30.45%
Tax Rate - - - - - - - -
Total Cost 31,104 17,688 13,524 8,967 8,522 6,233 4,768 36.67%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -1,010.06 -964.90 -1,216.85 -773.13 -692.01 0.00 591.04 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.37 -0.25 -0.29 -0.21 -0.26 -0.30 -0.29 4.14%
EPS Diluted -0.37 -0.25 -0.29 -0.21 -0.26 -0.30 -0.28 4.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.